The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Avdeev S.N.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Alyeva M.H.

Perm State Medical University named after Academician E.A. Wagner

Baranov A.A.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky

Bikmieva A.V.

Perm State Medical University named after Academician E.A. Wagner

Briko N.I.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Bulgakova V.A.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Vishneva E.A.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Gorelov A.V.

Central Research Institute of Epidemiology

Demko I.V.

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky

Dobrynina E.A.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine

Zhdanov K.V.

Military Medical Academy named after S.M. Kirov

Zhestkov A.V.

Samara State Medical University

Zajcev A.A.

Main Military Clinical Hospital named after Academician N.N. Burdenko;
Russian Biotechnological University (ROSBIOTECH)

Ignatova G.L.

South Ural State Medical University

Kozlov R.S.

Smolensk State Medical University

Korshunov V.A.

I.M. Sechenov First Moscow State Medical University

Kostinov M.P.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Kulichenko T.V.

N.I. Pirogov Russian National Research Medical University

Lobzin Ju.V.

Children’s Scientific and Clinical Center for Infectious Diseases

Mazankova L.N.

Russian Medical Academy of Continuous Professional Education

Namazova-Baranova L.S.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Polibin R.V.

I.M. Sechenov First Moscow State Medical University

Rtishhev A.Ju.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Selimzjanova L.R.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Sidorenko S.V.

Children’s Scientific and Clinical Center for Infectious Diseases

Tatochenko V.K.

National Medical Research Center for Children’s Health

Tkacheva O.N.

N.I. Pirogov Russian National Research Medical University

Fedoseenko M.V.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Fel’dbljum I.V.

Perm State Medical University named after Academician E.A. Wagner

Harit S.M.

Children’s Scientific and Clinical Center for Infectious Diseases

Chulanov V.P.

National Medical Research Center for Phthisiopulmonology and Infectious Diseases

Shubin I.V.

N.I. Pirogov Russian National Research Medical University

Federal Clinical Guidelines on Vaccination of pneumococcal infection in children and adults

Authors:

Avdeev S.N., Alyeva M.H., Baranov A.A., Bikmieva A.V., Briko N.I., Bulgakova V.A., Vishneva E.A., Gorelov A.V., Demko I.V., Dobrynina E.A., Drapkina O.M., Zhdanov K.V., Zhestkov A.V., Zajcev A.A., Ignatova G.L., Kozlov R.S., Korshunov V.A., Kostinov M.P., Kulichenko T.V., Lobzin Ju.V., Mazankova L.N., Namazova-Baranova L.S., Polibin R.V., Rtishhev A.Ju., Selimzjanova L.R., Sidorenko S.V., Tatochenko V.K., Tkacheva O.N., Fedoseenko M.V., Fel’dbljum I.V., Harit S.M., Chulanov V.P., Shubin I.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2023;26(9‑2): 3‑23

DOI: 10.17116/profmed2023260923

Read: 15141 times

Download PDF (RU)
Contact the author
Table of contents

FEDERAL CLINICAL GUIDELINES ON VACCINATION OF PNEUMOCOCCAL INFECTION IN CHILDREN AND ADULTS
FEDERAL CLINICAL GUIDELINES ON VACCINATION OF PNEUMOCOCCAL INFECTION IN CHILDREN AND ADULTS

To cite this article:

Avdeev SN, Alyeva MH, Baranov AA, et al. . Federal Clinical Guidelines on Vaccination of pneumococcal infection in children and adults. Russian Journal of Preventive Medicine. 2023;26(9‑2):3‑23. (In Russ.)
https://doi.org/10.17116/profmed2023260923

Подписка 2025-2 (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Risk factors for the iron defi­ciency anemia deve­lopment in infa­nts: pylot study. Russian Journal of Preventive Medi­cine. 2024;(6):53-59
Post-COVID syndrome in children: features of pathophysiology, diagnosis and therapy. Russian Journal of Preventive Medi­cine. 2024;(7):94-100
Physicians’ adhe­rence to clinical guidelines: impact on mortality in the treatment of solid tumors (a systematic review and meta-analysis). Medi­cal Technologies. Asse­ssment and Choice. 2024;(2):28-39
Hydrogen sulfide balneotherapy in comprehensive sana­torium-resort treatment of post-burn scars in children. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(3):32-40
Endo­metriosis and geni­tal malformations in children and adolescents. What do they have in common?. Russian Journal of Human Reproduction. 2024;(3):14-22
Lapa­roscopic nephrectomies and kidney rese­ctions in children. Piro­gov Russian Journal of Surgery. 2024;(7):61-72
Asso­ciation between previous appe­ndectomy and cognitive impairment in adults: a case-control study. Piro­gov Russian Journal of Surgery. 2024;(7):73-77
Effi­cacy of inte­nsive therapy for massive intraoperative blood loss in children: expe­rience of the Moro­zov Hospital. Piro­gov Russian Journal of Surgery. 2024;(7):103-110
ALK-positive anaplastic large cell lymphoma of para­nasal sinu­ses: two cases report and lite­rature review. Russian Journal of Archive of Pathology. 2024;(4):42-47
Traumatic gallbladder rupture in a 9-year-old child. Piro­gov Russian Journal of Surgery. 2024;(8):96-100

Diseases of pneumococcal etiology are an actual problem of practical health care. S. pneumoniae continues to be one of the leading causes of serious illnesses in adults and children, such as bacteremia, otitis media, sinusitis, meningitis, and pneumonia. Vaccination is recognized as the most effective method of preventing pneumococcal infection, which is the only way to significantly affect morbidity, mortality and stop the growth of antibiotic resistance. The guidelines were developed based on an analysis of studies published over the past 5 years and included in the EMBASE, MEDLINE, PubMed databases and the Cochrane library. The results of the analysis were peer-reviewed by independent experts, taking into account the opinions of primary care practitioners. The quality and level of evidence generated, as well as the strength of the recommendations based on them, were assessed in accordance with international criteria. These clinical guidelines review the epidemiology, social significance, pathogenesis, clinical forms of pneumococcal infection, and characterize vaccines for its prevention. Recommendations for the vaccination of pneumococcal infection in children and adults, including those belonging to various risk groups and with various comorbid conditions, are presented. The target audience of these recommendations are medical specialists: pediatricians, epidemiologists, general practitioners (family doctors), therapists, allergists-immunologists, pulmonologists and others. They can also be useful for students of residency and postgraduate programs, students of advanced training courses in these specialties.

Keywords:

vaccination
pneumococcal infection
clinical guidelines
children
adults
risk groups

Authors:

Avdeev S.N.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Alyeva M.H.

Perm State Medical University named after Academician E.A. Wagner

Baranov A.A.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky

Bikmieva A.V.

Perm State Medical University named after Academician E.A. Wagner

Briko N.I.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Bulgakova V.A.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Vishneva E.A.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Gorelov A.V.

Central Research Institute of Epidemiology

Demko I.V.

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky

Dobrynina E.A.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine

Zhdanov K.V.

Military Medical Academy named after S.M. Kirov

Zhestkov A.V.

Samara State Medical University

Zajcev A.A.

Main Military Clinical Hospital named after Academician N.N. Burdenko;
Russian Biotechnological University (ROSBIOTECH)

Ignatova G.L.

South Ural State Medical University

Kozlov R.S.

Smolensk State Medical University

Korshunov V.A.

I.M. Sechenov First Moscow State Medical University

Kostinov M.P.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Kulichenko T.V.

N.I. Pirogov Russian National Research Medical University

Lobzin Ju.V.

Children’s Scientific and Clinical Center for Infectious Diseases

Mazankova L.N.

Russian Medical Academy of Continuous Professional Education

Namazova-Baranova L.S.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Polibin R.V.

I.M. Sechenov First Moscow State Medical University

Rtishhev A.Ju.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Selimzjanova L.R.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Sidorenko S.V.

Children’s Scientific and Clinical Center for Infectious Diseases

Tatochenko V.K.

National Medical Research Center for Children’s Health

Tkacheva O.N.

N.I. Pirogov Russian National Research Medical University

Fedoseenko M.V.

Scientific and Clinical Center No. 2 Russian Scientific Center for Surgery named after academician B.V. Petrovsky;
N.I. Pirogov Russian National Research Medical University

Fel’dbljum I.V.

Perm State Medical University named after Academician E.A. Wagner

Harit S.M.

Children’s Scientific and Clinical Center for Infectious Diseases

Chulanov V.P.

National Medical Research Center for Phthisiopulmonology and Infectious Diseases

Shubin I.V.

N.I. Pirogov Russian National Research Medical University

List of references:

  1. Vakcinoprofilaktika pnevmokokkovoj infekcii u detej. Rukovodstvo po profilaktike zabolevanij/sindromov. Ministerstvo zdravooxraneniya Rossijskoj Federacii, Soyuz pediatrov Rossii. M.: Pediatr’;2018. (In Russ.).
  2. Epidemiologija, klinika i profilaktika pnevmokokkovoj infekcii: Uchebnoe posobie dlja vrachej. Pod red. Briko N.I.: Nizhnij Novgorod: Remedium Privolzh’e; 2017. (In Russ.).
  3. GBD 2019 Antimicrobial Resistance Collaborators (2022). Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England), 400(10369), 2221-2248. https://doi.org/10.1016/S0140-6736(22)02185-7
  4. Pollard AJ, Perrett KP, Beverley PC. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nature Reviews Immunology. 2009;9(3):213-220.  https://doi.org/10.1038/nri2494
  5. Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG. Prevention and management of glucocorticoid-induced side effects: A comprehensive review. Infectious complications and vaccination recommendations. J Am Acad Dermatol. 2017;76(2):191-198.  https://doi.org/10.1016/j.jaad.2016.02.1240
  6. Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nature Reviews Immunology. 2009;9(3):185-194.  https://doi.org/10.1038/nri2508
  7. Huijts SM, van Werkhoven CH, Bolkenbaas M, Grobbee DE, Bonten MJM. Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderly. Vaccine. 2017;35(34):4444-4449. https://doi.org/10.1016/j.vaccine.2017.01.071
  8. Shea KM, Edelsberg J, Weycker D, Farkouh RA, Strutton DR, Pelton SI. Rates of pneumococcal disease in adults with chronic medical conditions. Open forum infectious diseases. 2014;1(1):ofu024. https://doi.org/10.1093/ofid/ofu024
  9. Luján M, Burgos J, Gallego M, Falcó V, Bermudo G, Planes A, Fontanals D, Peghin M, Monsó E, Rello J. Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: implications for vaccine strategies. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2013;57(12): 1722-1730. https://doi.org/10.1093/cid/cit640
  10. Rukovodstvo po klinicheskoj immunologii v respiratornoj medicine. 2-e izd., dop. Pod red. Kostinov M.P., Chuchalin A.G. M.: MDV; 2018. (In Russ.).
  11. Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan Qld.). 2020;12:11.  https://doi.org/10.1186/s41479-020-00074-3
  12. Gosudarstvennyj doklad «O sostojanii sanitarno-jepidemiologicheskogo blagopoluchija naselenija v Rossijskoj Federacii v 2022 g.». M.: Federal’naja sluzhba ohrany po nadzoru v sfere zashhity prav potrebitelej I blagopoluchija cheloveka; 2023. (In Russ.).
  13. Briko NI, Korshunov VA, Lomonosov KS. Pneumococcal infection in Russia: state of the issue. Annals of the Russian academy of medical sciences. 2021;76:1:28-42. (In Russ.). https://doi.org/10.15690/vramn1404
  14. Zakharenkov I.A., Rachina S.A., Dekhnich N.N., Kozlov R.S., Sinopalnikov A.I., Ivanchik N.V., Yatsyshina S.B., Elkina M.A., Archipenko M.V., Gordeeva S.A., Lebedeva M.S., Portnyagina U.S. Etiology of severe community-acquired pneumonia in adults: results of the first Russian multicenter study. Therapeutic Archive. 2020;92(1):36-42. (In Russ.). https://doi.org/10.26442/00403660.2020.01.000491
  15. Bobylev AA, Rachina SA, Avdeev SN, Kozlov RS, Sukhorukova MV, Yatsyshina SB, El’kina MA, Yudanova TA. Etiology of community-acquired pneumonia in patients with chronic heart failure. Pulmonologiya. 2019;29(3):293-301. (In Russ.) https://doi.org/10.18093/0869-0189-2019-29-3-293-301
  16. Kozlov RS, Krechikova OI, Murav’ev AA, Mironov KO, Platonov AE, Dunaeva EA, Tatochenko VK, Shherbakov ME, Rodnikova VJu, Romanenko VV, Saf’janov K N. Rezul’taty issledovanija rasprostranennosti v Rossii vnebol’nichnoj pnevmonii i ostrogo srednego otita u detej v vozraste do 5 let (PAPIRUS). Ro’ S. pneumoniae i H. influenzae v jetiologii dannyh zabolevanij. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2013; 15(4):246-260. (In Russ.).
  17. Martynova GP, Protasova IN, Kutischheva IA, Ovchinnikova OP, Rokatansky NA, Konchakov MP. Pneumococcal meningitis: clinical and epidemiological features, and circulating pathogens’ serotype distribution in Krasnoyarsk territory. Journal Infectology. 2020;12(2):43-49. (In Russ.). https://doi.org/10.22625/2072-6732-2020-12-2-43-49
  18. Koroleva IS. Informacionno-analiticheskij obzor «Meningokokkovaja infekcija i gnojnye bakteria’’nye meningity a Rossijskoj federacii, 2020 god». (In Russ.).
  19. Protasova IN, Feldblium IV, Bakhareva NV, Ovchinnikova OP, Domracheva SV. Preventive Efficacy of Pneumococcal Conjugated Vaccine (Population Aspects). Epidemiology and Vaccinal Prevention. 2021;20(6):37-55. (In Russ.). https://doi.org/10.31631/2073-3046-2021-20-6-37-55
  20. Lazareva MA, Kulichenko TV, Alyab’eva NM, Ponamarenko OA, Lazareva AV, Katosova LK, Mayanskii NA. Nasopharyngeal carriage of Streptococcus pneumoniae in orphans, preschool children and unorganized children under 5 years. Current Pediatrics. 2015;14(2):246-255. (In Russ.). https://doi.org/10.15690/vsp.v14i2.1293
  21. Kozlov RS, Sivaja OV, Krechikova OI, Ivanchik NV. Gruppa issledovatelej proekta «PeGAS». Antimicrobial Resistance of Streptococcus pneumoniae in Russia over the 1999–2009: Results of Multicenter Prospective Study PEHASus. Klinicheskaja Mikrobiologija i Antimikrobnaja Himioterapija. 2010; 12(4):329-341. (In Russ.).
  22. Savinova TA, Sidorenko SV, Budanov SV, Grudinina SA. Dinamika rasprostranenija rezistentnosti k betalaktamnym antibiotikam sredi Streptococcus pneumoniae i ejo klinicheskaja znachimost’. Antibiotiki i himioterapija. 2010; 55(1-2):12-20. (In Russ.).
  23. Kozlov RS, Suhorukova MV, Sidorenko SV, Jejdel’shtejn MV, Skleenova EJu, Ivanchik NV, Mikotina AV, Gostev VV, Lazareva IV, Kalinogorskaya OS, Volkova MO, Dekhnich AV. In vitro Ceftaroline Activity against Major Bacterial Pathogens n Russia: Results of Multicenter Study. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2015;17(3):217-226. (In Russ.).
  24. Kalinogorskaja OS, Belanov SS, Volkova MO, Gostev VV, Sidorenko SV. Antibiotikorezistentnos’ i serotipovyj sostav Streptococcus pneumoniae vydelennyh u detej v Sankt-Peterburge v 2010—2013 gg. Antibiotiki i himioterapija. 2015;60(1-2):10-18. (In Russ.).
  25. Torumkuney D, Mayanskiy N, Edelstein M, Sidorenko S, Kozhevin R, Morrissey I. Results from the Survey of Antibiotic Resistance (SOAR) 2014—16 in Russia. The Journal of antimicrobial chemotherapy. 2018;73(suppl 5):14-21.  https://doi.org/10.1093/jac/dky065
  26. Sidorenko SV, Savinova TA, Il’ina EN, Syrochkina MA. Populjacionnaja struktura pnevmokokkov so snizhennoj chuvstvitel’nost’ju kandomizedu i perspektivy antipnevmokokkovoj vakcinacii dlja sderzhivanija rasprostranenija antibakterial’noj rezistentnosti. Antibiotiki i himioterapija. 2011;56:5-6 11. (In Russ.).
  27. World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper — February 2019. Accessed on September 08, 2022. https://www.who.int/immunization/policy/position_papers/pneumococcus/en/
  28. Tatochenko V, Sidorenko S, Namazova-Baranova L, Mayanskiy N, Kulichenko T, Baranov A, Lobzin Y, Kharit S, Kozlov R, Andreeva I, Muravjev A, Chagaryan A, Koroleva I, Beloshitskiy G, Mironov K, Degtyareva E, Reinert RR. Streptococcus pneumoniae serotype distribution in children in the Russian Federation before the introduction of pneumococcal conjugate vaccines into the National Immunization Program. Expert review of vaccines. 2014;13(2):257-264.  https://doi.org/10.1586/14760584.2013.871205
  29. Sidorenko S, Rennert W, Lobzin Y, Briko N, Kozlov R, Namazova-Baranova L, Tsvetkova I, Ageevets V, Nikitina E, Ardysheva A, Bikmieva A, Bolgarova E, Volkova M, Verentsova I, Girina A, Gordeeva N, Demko I, Dushchenko A, Evseeva G, Zharkova L, ... Sheglinkova N. Multicenter study of serotype distribution of Streptococcus pneumoniae nasopharyngeal isolates from healthy children in the Russian Federation after introduction of PCV13 into the National Vaccination Calendar. Diagnostic microbiology and infectious disease. 2020;96(1):114914. https://doi.org/10.1016/j.diagmicrobio.2019.114914
  30. Sidorenko S, Rennert W, Ageevets V, et al. Streptococcus pneumoniae serotype distribution in healthy and sick children after 13-valent pneumococcal conjugate vaccine introduction in Russia amid COVID-19 pandemia. 12 International Symposium on Pneumococci and Pneumococcal Diseases. Toronto, Canada. 19-23 June 2022. Abstract 216. 
  31. Kozlov RS, Muravyev AA, Chagaryan AN, Ivanchik NV, Kurkova AA, Kuzmenkov AYu, Trushin IV, Sukhorukova MV, Cvetkova IA, Morozova OA, Kirillova GS, Popova LD, Moskvitina EN, Petrova TA, Martyanova NM, Ershova MG, Bykonya SA. The prevalence and antimicrobial susceptibility of circulating S. pneumoniae serotypes in adult population in Russia (epidemiological study «SPECTRUM»). Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2021;23(2):127-137. (In Russ.). https://doi.org/10.36488/cmac.2021.2.127-137
  32. Rasporjazhenie Pravitel’stva Rossijskoj Federacii ot 18.09.2020 №2390-r «Ob utverzhdenii Strategii razvitija immunoprofilaktiki infekcionnyh boleznej na period do 2035 goda». Accessed on May 15, 2023. (In Russ.).
  33. Rasporjazhenie Pravite’stva Rossijskoj Federacii ot 29.03.21 №774-r «Ob utverzhdenii plana meroprijatij po realizacii Strategii razvitija immunoprofilaktiki infekcionnyh boleznej na period do 2035 g.» Accessed on May 15, 2023. (In Russ.). hhttps://www.garant.ru/products/ipo/prime/doc/400425985/
  34. Instrukcija po primeneniju lekarstvennogoandomizea dlja medicinskogo primenenijaandomizea Sinfloriks — vakcina 10-valentnaja pnevmokokkovaja polisaharidnaja, konjugirovannaja s D-proteinom netipiruemoj Haemophilus influenzae, stolbnjachnym i difterijnym anatoksinami, adsorbirovannaja. LP -001412. Accessed on May 15, 2023. (In Russ.). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=150b2fd7-dd3c-4227-aa69-61c4de6db279
  35. Instrukcija po primeneniju lekarstvennogoandomizea dlja medicinskogo primenenija Prevenar 13 — vakcina trinadcativalentnaja pnevmokokkovaja polisaharidnaja kon#jugirovannaja adsorbirovannaja. LP 000798-031011. Accessed on May 15, 2023. (In Russ.). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=fa171426-1eca-44bc-81f4-6031a67504f1
  36. Instrukcija po medicinskomu primeneniju lekarstvennogoandomizea PNEMOTEKS — vakcina pnevmokokkovaja, polisaharidnaja, konjugirovannaja, adsorbirovannaja, trinadcativalentnaja, LP 007205. Accessed on May 15, 2023. (In Russ.). https://grls.rosminzdrav.ru
  37. Instrukcija po medicinskomu primeneniju lekarstvennogo preparata Pnevmovaks 23 — vakcina pnevmokokkovaja polivalentnaja Pnevmovaks 23 LP-003441-020216. Accessed on May 15, 2023. (In Russ.). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=32e86091-0622-4dce-aa51-9247900477f9
  38. Nilsson L, Brockow K, Alm J, Cardona V, Caubet JC, Gomes E, Jenmalm MC, Lau S, Netterlid E, Schwarze J, Sheikh A, Storsaeter J, Skevaki C, Terreehorst I, Zanoni G. Vaccination and allergy: EAACI position paper, practical aspects. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology. 2017;28(7): 628-640.  https://doi.org/10.1111/pai.12762
  39. Kostjanaja IE, Mejsner AF, Aksenova VA, Baturo AP. Opyt primenenija vakcin Pnevmo 23 i Vaksigripp u inficirovannyh mikobakterijami tuberkuleza detej grupp riska. Vakcinacija. 2002;1(19):10-12. (In Russ.).
  40. Kostinov MP, Tarasova AA. Vakcinoprofilaktika pnevmokokkovoj infekcii i grippa pri autoimmunnyh zabolevanijah. M. 2009. (In Russ.).
  41. Siriwardena AN, Gwini SM, Coupland CA. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ: Canadian Medical Association journal = journal de’ Association medicalerandomizede. 2010;182(15):1617-1623. https://doi.org/10.1503/cmaj.091891
  42. Skochilova TV, Vorob’eva VA, Kostinov MP, Tarasova AA, Korovkina TI, Yushkova IY, Lukachev IV. Vaccination against pneumococcal and influenza infections in children and adolescents with type 1 diabetes. Problemy jendokrinologii. 2009;4(55):6-11. (In Russ.).
  43. Vakcinacija vzroslyh s bronholegochnoj patologiej: Rukovodstvo dlja vrachej. Pod red. Kostinova M.P. M. 2013. (In Russ.).
  44. Kratkie algoritmy vedenija pacientov na jetape okazanija pervichnoj mediko-sanitarnoj pomoshhi. Posobie dlja vrachej-terapevtov. Pod red. Drapkinoj O.M. M. 2019. (In Russ.).
  45. Prikaz MZ RF ot 06 dekabrja 2021 g. №122n «Ob utverzhdenii naciona’nogo kalendarja profilakticheskih privivok i kalendarja profilakticheskih privivok po jepidemicheskim pokazanijam» Accessed on May 15, 2023. (In Russ.). https://publication.pravo.gov.ru/Document/View/0001202112200070
  46. Baranov AA, Namazova-Baranova LS, Brico NI, Lobzin YuV, Kozlov RS, Kostinov MP, Koroleva IS, Rudakova AV, Sidorenko SV, Tatochenko VK, Kharit SM, Fedoseenko MV, Vishneva EA, Selimzyanova LR. Vaccine Prevention of Pneumococcal Infection in Children. Pediatric pharmacology. 2018;15(3):200-211. (In Russ.). https://doi.org/10.15690/pf.v15i3.1899
  47. Ignatova GL, Rodionova OV. Clinical efficacy of vaccination of patients with chronic lung diseases with conjugated pneumococcal vaccine in Chelyabinsk pulmonological centre. Pulmonologiya. 2013;(6):38-42. (In Russ.). https://doi.org/10.18093/0869-0189-2013-0-6-739-750
  48. Alfageme I, Vazquez R, Reyes N, Muñoz J, Fernández A, Hernandez M, Merino M, Perez J, Lima J. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax. 2006;61(3):189-195.  https://doi.org/10.1136/thx.2005.043323
  49. Ot profilakticheskogo k terapevticheskomu jeffektu vakcin protiv pnevmokokkovoj i gemofil’noj tipa b infekcij u pacientov s bronholegochnoj patologiej. Pod red. Kostinova M.P. M. 2007. (In Russ.).
  50. Kostinov MP, Zhestkov AV, Protasov AD, Kostinova TA, Pakhomov D., Chebykina AV, Magarshak OO. Comparison of quality of life in patients with chronic obstructive pulmonary disease vaccinated with 13-valent conjugate pneumococcal vaccine or 23-valent polysaccharide pneumococcal vaccine. Pulmonologiya. 2015;25(2):163-166. (In Russ.). https://doi.org/10.18093/0869-0189-2015-25-2-163-166
  51. Krysanov IS. Analysis the cost of chronic obstructive pulmonary disease in Russian Federation. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2014;(2):51-56. (In Russ.).
  52. Ignatova GL, Antonov VN. Narushenija funkcii vneshnego dyhanija pri sochetannom techenii HOBL i IBS. Consilium Medicum. 2014;11(16):32-36. (In Russ.).
  53. Eurich DT, Johnstone JJ, Minhas-Sandhu JK, Marrie TJ, Majumdar SR. Pneumococcal vaccination and risk of acute coronary syndromes in patients with pneumonia: population-based cohort study. Heart (British Cardiac Society). 2012;98(14):1072-1077. https://doi.org/10.1136/heartjnl-2012-301743
  54. Lamontagne F, Garant MP, Carvalho JC, Lanthier L, Smieja M, Pilon D. Pneumococcal vaccination and risk of myocardial infarction. CMAJ: Canadian Medical Association journal = journal de’ Association medicalerandomizede. 2012;179(8):773-777.  https://doi.org/10.1503/cmaj.070221
  55. Kostinov MP, Protasov AD, Zhestkov AV, Polishhuk VB. Perspectives of vaccination with 13!valent pneumococcal vaccine in adults with chronic respiratory diseases. Pulmonologiya. 2014;(4):57-63. (In Russ.). https://doi.org/10.18093/0869-0189-2014-0-4-57-63
  56. Gilbertson DT, Guo H, Arneson TJ, Collins AJ. The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association — European Renal Association. 2011; 26(9):2934-2939. https://doi.org/10.1093/ndt/gfq853
  57. McDonald HI, Thomas SL, Millett ERC, Quint J, Nitsch D. Do influenza and pneumococcal vaccines prevent community-acquired respiratory infections among older people with diabetes and does this vary by chronic kidney disease? A cohort study using electronic health records. BMJ open diabetes research & care. 2017;5(1):e000332. https://doi.org/10.1136/bmjdrc-2016-000332
  58. Zhilyaev EV, Lukina GV, Murtazalieva DA, Koltsova EN, Shmidt EI, Lytkina KA, Shmit’ko AV, Blagovidov DA, Kostinov MP. The effect of pneumococcal vaccination on the risk of infectious complications in patients with rheumatoid arthritis treated with targeted anti-inflammatory drugs (data from the Moscow Unified Arthritis Registry (MUAR)). RMJ. 2021;7:7-12. (In Russ.).
  59. Saokaew S, Rayanakorn A, Wu DB, Chaiyakunapruk N. Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review. PharmacoEconomics. 2016;34(12):1211-1225. https://doi.org/10.1007/s40273-016-0439-3
  60. Rudakova AV, Briko NI, Lobzin YuV, Namazova-Baranova LS, Avdeev SN, Koroleva IS, Korshunov VA, Kostinov MP, Kontsevaya AV, Shepel RN, Drozdova lYu, Drapkina OM. Cost-effectiveness of vaccination of elderly citizens against pneumococcal infection in the Russian Federation. Profilakticheskaya Meditsina. 2021;24(12):41-48. (In Russ.) https://doi.org/10.17116/profmed20212412141
  61. Marra F, Zhang A, Gillman E, Bessai K, Parhar K, Vadlamudi NK. The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2020;99:204-213.  https://doi.org/10.1016/j.ijid.2020.07.038
  62. Jaiswal V, Ang SP, Lnu K, Ishak A, Pokhrel NB, Chia JE, Hajra A, Biswas M, Matetic A, Dhatt R, Mamas MA. Effect of Pneumococcal Vaccine on Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022;11(13):3799. https://doi.org/10.3390/jcm11133799
  63. Rezolyuciya zasedaniya obshhestvennogo koordinacionnogo soveta po pnevmokokkovoj infekcii i vakcinacii v Rossii. Pediatricheskaya farmakologiya. 2016;13(1):76-79. (In Russ.). https://doi.org/10.15690/pf.v13i1.1522
  64. Mayanskij NA, Alyab’eva NM, Ponomarenko OA, Kulichenko TV, Artemova IV, Lazareva AV, Brzhozovskaya EA, Shamina OV, Katosova LK. Dinamika rasprostranennosti serotipov i antibiotikorezistentnosti nosoglotochny’x pnevmokokkov, vy’delenny’x u detej v 2010—2016 gg.: rezul’taty’ retrospektivnogo kogortnogo issledovaniya. Voprosy’ sovremennoj pediatrii. 2017;16(5):413-423. (In Russ.). https://doi.org/10.15690/vsp.v16i5.1806
  65. Baranov AA, Namazova-Baranova LS, Mayanskij NA, Kulichenko TV, Polunina TA, Lazareva AV, Alyab’eva NM, Katosova LK, Ponomarenko OA, Koltunov IE, Ivanenko AM, Degtyaryova EA, Kondratenko NV, Korsunsky AA, Konstantinov KV, Tulupov DA, Lazareva MA. Role of streptococcus pneumoniae in the structure of bacterial infections in the children hospitalized to inpatient hospitals in Moscow in 2011–2012. Pediatricheskaya farmakologiya. 2013;10(5):6-12. (In Russ.). https://doi.org/10.15690/pf.v10i5.816
  66. Postanovlenie Glavnogo gosudarstvennogo sanitarnogo vracha RF ot 28.01.21 №4 «Ob utverzhdenii sanitarnyh pravil i norm SanPiN 3.3686-21 «Sanitarno-jepidemiologicheskie trebovanija po profilaktike infekcionnyh bolezne»». Accessed on May 15, 2023. (In Russ.). https://www.rospotrebnadzor.ru/files/news/SP_infections_compressed.pdf
  67. Berman-Rosa M, ‘Donnell S, Barker M, Quach C. Efficacy and Effectiveness of the PCV-10 and PCV-13 Vaccines Against Invasive Pneumococcal Disease. Pediatrics. 2020;145(4):e20190377. https://doi.org/10.1542/peds.2019-0377
  68. de Sévaux JL, Venekamp RP, Lutje V, Hak E, Schilder AG, Sanders EA, Damoiseaux RA. Pneumococcal conjugate vaccines for preventing acute otitis media in children. The Cochrane database of systematic reviews. 2020; 11(11):CD001480. https://doi.org/10.1002/14651858.CD001480.pub6
  69. Kroger A, Bahta L, Hunter P. General Best Practice Guidelines for Immunization. Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). Vaccine Administration. Accessed on September 20, 2022. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html
  70. Drozdenko TS, Harit SM, Dovgaljuk IF. Taktika vakcinacii detej s razlichnymi projavlenijami tuberkuleznoj infekcii. Pediatricheskaja farmakologija. 2011;8(4):60-63. (In Russ.).
  71. CDC. Pneumococcal Disease. Epidemiology and Prevention of Vaccine-Preventable Diseases. The Pink Book: Course Textbook — 13th Edition (2015); CDC. Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. September 4. 2015;64(34);944-947. Accessed on September 20, 2022. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6434a4.htm
  72. UpToDate EI. Tuomanen Pneumococcal vaccination in children. Accessed on September 20, 2022. https://www.uptodate.com/contents/pneumococcal-vaccination-in-children#
  73. Vardanjani HM, Borna H, Ahmadi A. Effectiveness of pneumococcal conjugate vaccination against invasive pneumococcal disease among children with and those without HIV infection: a systematic review and meta-analysis. BMC infectious diseases. 2019;19(1):685.  https://doi.org/10.1186/s12879-019-4325-4
  74. Chuchalin AG, Avdeev SN, Aisanov ZR, Belevskiy AS, Leshchenko IV, Ovcharenko SI, Shmelev EI. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. Pulmonologiya. 2022;32(3):356-392. (In Russ.). https://doi.org/10.18093/0869-0189-2022-32-3-356-392
  75. Avdeev SN, Demko IV, Zaytsev AA, Ignatova GL, Kravchenko NYu, Leshchenko IV, Ovcharenko SI, Sinopal’nikov AI, Frantsuzevich LY. Federal guidelines on diagnosis and treatment of chronic bronchitis. Pulmonologiya. 2022;32(3):448-472. (In Russ.). https://doi.org/10.18093/0869-0189-2022-32-3-448-472
  76. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I. Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;58(3):309-318.  https://doi.org/10.1093/cid/cit816
  77. Tatochenko VK, Ozereckovskij NA. Immunoprofilaktika-2018. Spravochnik. 13-e izd., rasshir. M.: Borges; 2018. Kostinov MP, Chuchalin AG, red. Rukovodstvo po klinicheskoj immunologii v respiratornoj medicine. 2-e izd., dop. M.: MDV; 2018. (In Russ.).
  78. Falkenhorst G, Remschmidt C, Harder T, Wichmann O, Glodny S, Hummers-Pradier E, Ledig T, Bogdan C. Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2016;59(12): 1623-1657. (In German). https://doi.org/10.1007/s00103-016-2466-9
  79. Gonzalez-Romo F, Picazo JJ, Rojas AG, et al. Con — sensus document on pneumococcal vaccination in adults at risk by age and underlying clinical conditions. 2017 Update]. Rev Esp Quimioter. 2017;30(2):142-168. (In Spanish). Accessed on September 20, 2022. https://www.seq.es/seq/0214-3429/30/2/gonzalez15feb2017.pdf
  80. Australian Government Department of Health. Australian Immunisation Handbook. The National Immunisation Program. Accessed on September 20, 2022. https://www.health.gov.au/internetandomize/publishing.nsf/Content/national-immunisation-program-schedule
  81. Center for Disease Control and Prevention. Pneumococcal Diseases. Pneumococcal Vaccination. Accessed on September 20, 2022. https://www.cdc.gov/pneumococcal/vaccination.html
  82. Tin Tin Htar M, Stuurman AL, Ferreira G, Alicino C, Bollaerts K, Paganino C, Reinert RR, Schmitt HJ, Trucchi C, Vestraeten T, Ansaldi F. Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies. PloS one. 2017; 12(5):e0177985. https://doi.org/10.1371/journal.pone.0177985
  83. Vaccine Recommendations and Guidelines of the ACIP. Accessed on September 20, 2022. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.html
  84. Chaaban S, Sadikot RT. Bacterial Infections Associated with Immunosuppressive Agents Commonly Used in Patients with Interstitial Lung Diseases. Pathogens (Basel, Switzerland). 2023;12(3):464.  https://doi.org/10.3390/pathogens12030464
  85. U.S. National Library of Medicine. Pneumococcal Vaccine in Untreated CLL (Chronic Lymphocytic Leukemia) Patients. ClinicalTrials.gov NCT01892618. Accessed on May 25, 2023. https://clinicaltrials.gov/ct2/show/NCT01892618?term=NCT01892618&rank=1
  86. U.S. National Library of Medicine. VACcination In Methotrexate Treated Rheumatoid Arthritis Patients (VACIMRA). ClinicalTrials.gov NCT01942174. Accessed on September 20, 2022. https://clinicaltrials.gov/ct2/show/NCT01942174?term=NCT01942174&rank=1
  87. Golodnova SO, Fel’dbljum IV, Semerikov VV, Nikolenko VV, Zakharova YuA. The Prevalence of Carriage of Streptococcus pneumoniae among Medical Specialists and Evaluation of their Vaccination. Jepidemiologija i vakcinoprofilaktika. 2014;1(74):50-54. (In Russ.).
  88. Kozlov RS, Avdeev SN, Briko NI, Bilichenko TN, Kostinov MP, Sidorenko SV, Kharit SM, Sinopalnikov AI, Zaitsev AA, Shubin IV, Demko IV, Ignatova GL, Rachina SA, Feldblum IV. Vaccination against pneumococcal infections in adults. Rezoljucija soveta jekspertov (Moskva, 16 dekabrja 2017 g.). Klinicheskaja Mikrobiologija i Antimikrobnaja Himioterapija. 2018; 20(1):5-8. (In Russ.).
  89. Nikolenko VV, Fel’dbljum IV, Golodnova SO, Vorob’eva NN. Medicinskie rabotniki kak gruppa riska po pnevmokokkovoj infekcii. Medicinskij Al’manah. 2014;4(34):30-34. (In Russ.).
  90. McLaughlin JM, Jiang Q, Isturiz RE, Sings HL, Swerdlow DL, Gessner BD, Carrico RM, Peyrani P, Wiemken TL, Mattingly WA, Ramirez JA, Jodar L. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2018;67(10):1498-1506. https://doi.org/10.1093/cid/ciy312
  91. Greenberg RN, Gurtman A, Frenck RW, Strout C, Jansen KU, Trammel J, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60—64 years of age. Vaccine. 2014;32(20):2364-2374. https://doi.org/10.1016/j.vaccine.2014.02.002
  92. Paradiso PR. Pneumococcal conjugate vaccine for adults: a new paradigm. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012;55(2):259-264.  https://doi.org/10.1093/cid/cis359
  93. U.S. National Library of Medicine. Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13 and Pneumovax 23 in Healthy Participants 50 Years of Age and Older (V110-029). Accessed on September 20, 2022. https://clinicaltrials.gov/ct2/show/NCT02225587
  94. Demko IV, Korchagin EE, Gordeeva NV, Kraposhina AYu, Solo’eva IA. An experience of vaccination against pneumococcal infection of adults at Krasnoyarsk krai. Pulmonologiya. 2017;27(1):21-28. (In Russ.). https://doi.org/10.18093/0869-0189-2017-27-1-21-28
  95. Avdeev SN, Dekhnich AV, Zaytsev AA, Kozlov RS, Rachina SA, Rudnov VA, Sinopal’nikov AI, Tyurin IE, Fesenko OV, Chuchalin AG. Federal guidelines on diagnosis and treatment of community-acquired pneumonia. Pulmonologiya. 2022;32(3):295-355. (In Russ.). https://doi.org/10.18093/0869-0189-2022-32-3-295-355
  96. Ovchinnikov JuV, Zajcev AA, Sinopal’nikov AI i dr. Diagnostika, lechenie i vakcinoprofilaktika vnebol’nichnoj pnevmonii u voennosluzhashhih. Metodicheskie ukazanija po lecheniju vnebol’nichnoj pnevmonii u voennosluzhashhih. GVKG imeni N.N. Burdenko. M. 2015. (In Russ.).
  97. Sinopal’nikov AI, Zajcev AA. Analiz sostojanija pul’monologicheskoj pomoshhi v Vooruzhennyhandomii puti ee uluchshenija. Voenno-medicinskij zhurnal. 2008;329:8:31-40. (In Russ.).
  98. Ignatova GL, Avdeev SN, Antonov VN. Comparative effectiveness of pneumococcal vaccination with PPV23 and PCV13 in COPD patients over a 5-year follow-up cohort study. Scientific reports. 2021;11(1):15948. https://doi.org/10.1038/s41598-021-95129-w
  99. Zajcev AA, Akimkin VG, Briko NI, Krjukov EV, Shubin IV, Antipushina DN, Sergeeva NV. Jepidemiologija i vakcinoprofilaktika pnevmokokkovyh infekcij u voennosluzhashhih. Voenno-medicinskij zhurnal. 2019;340:1:39-45. (In Russ.).
  100. Prymula R, Siegrist CA, Chlibek R, Zemlickova H, Vackova M, Smetana J, Lommel P, Kaliskova E, Borys D, Schuerman L. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label,andomizedd controlled trials. Lancet. 2009;374(9698):1339-1350. https://doi.org/10.1016/S0140-6736(09)61208-3
  101. Allergologija i immunologija: Naciona’noe rukovodstvo. Pod red. Haitova R.M., I’inoj N.I. M. 2014. (In Russ.).
  102. Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, Breedveld FC, ‘Amelio R, Dougados M, Kapetanovic MC, van Laar JM, de Thurah A, Landewé RB, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, ... Elkayam O. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Annals of the rheumatic diseases. 2020;79(1):39-52.  https://doi.org/10.1136/annrheumdis-2019-215882
  103. Klinicheskie rekomendacii «Revmatoidnyj artrit» (utverzhdeny Ministerstvom zdravoohranenija RF, 2021 g. Accessed on May 15, 2023. (In Russ.). https://www.garant.ru/products/ipo/prime/doc/402775973/
  104. Metodicheskie ukazaniya MU 3.3.1.1095-02 3.3.1 Vakcinoprofilaktika. Medicinskie protivopokazaniya k provedeniyu profilakticheskix privivok preparatami nacional’nogo kalendarya privivok. (In Russ.).
  105. Instrukciya po medicinskomu primeneniyu lekarstvennogo preparata «Allergen iz domashnej py’li dlya diagnostiki i lecheniya» №000893/01 ot 23.01.23. Accessed on May 25, 2023. (In Russ.). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=8ec37da7-8dd1-4b3f-a309-d9cae2c7e3f8
  106. Worm M, Pfaar O. Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysis. Allergol Select. 2023;7:84-89.  https://doi.org/10.5414/ALX02390E
  107. Instrukciya po primeneniyu lekarstvennogo preparata «STALORAL’ «Allergen kleshhej» LSR-008340/10-21-316. Accessed on May 25, 2023. (In Russ.). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=2418a2e0-c5d3-48ce-8ecd-1883204a7b61
  108. Instrukciya po primeneniyu lekarstvennogo preparata «FOSTAL’ «Allergen py’l’cy derev’ev» LSR-007904/08 ot 27.10.16. Accessed on May 25, 2023. (In Russ.). https://grls.rosminzdrav.ru/GRLS.aspx?RegNumber=&MnnR=&lf=&TradeNmR=%d1%84%d0%be%d1%81%d1%82%d0%b0%d0%bb%d1%8c&OwnerName=&MnfOrg=&MnfOrgCountry=&isfs=0&regtype=1%2c6&pageSize=10&order=Registered&orderType=desc&pageNum=1
  109. Instrukciya po medicinskomu primeneniyu lekarstvennogo preparata «Ragvizaks» LP-004529-29092020. Accessed on May 25, 2023. (In Russ.). https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=b823f382-fdaf-4a1e-abb0-8ab84ec2bd63
  110. Masieri S, Bachert C, Ojeda P, Kim CK, Cavaliere C, Ciprandi G; Study Group on AIT & Vaccinations. Allergen Immunotherapy management during vaccinations: An international survey. World Allergy Organ J. 2021;14(11): 100601. https://doi.org/10.1016/j.waojou.2021.100601
  111. Pfaar O, Ankermann T, Augustin M, Bubel P, Böing S, Brehler R, Eng PA, Fischer PJ, Gerstlauer M, Hamelmann E, Jakob T, Kleine-Tebbe J, Kopp MV, Lau S, Mülleneisen N, Müller C, Nemat K, Pfützner W, Saloga J, Strömer K, Schmid-Grendelmeier P, Schuster A, Sturm GJ, Taube C, Szépfalusi Z, Vogelberg C, Wagenmann M, Wehrmann W, Werfel T, Wöhrl S, Worm M, Wedi B; Commenting participation and process support; Kaul S, Mahler V, Schwalfenberg A. Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD). Allergol Select. 2022;6:6:167-232.  https://doi.org/10.5414/ALX02331E
  112. Klimek L, Pfaar O, Hamelmann E, Kleine-Tebbe J, Taube C, Wagenmann M, Werfel T, Brehler R, Novak N, Mülleneisen N, Becker S, Worm M. COVID-19 vaccination and allergen immunotherapy (AIT) — A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI). Allergol Select. 2021;5:251-259.  https://doi.org/10.5414/ALX02245E
  113. Jutel M, Torres MJ, Palomares O, Akdis CA, Eiwegger T, Untersmayr E, Barber D, Zemelka-Wiacek M, Kosowska A, Palmer E, Vieths S, Mahler V, Canonica WG, Nadeau K, Shamji MH, Agache I. COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations. Allergy. 2022;77(8):2313-2336. https://doi.org/10.1111/all.15252
  114. Ullrich D, Ullrich K, Mussler S, Thum-Oltmer S. Vaccination during concurrent subcutaneous immunotherapy: safety of simultaneous application. Eur Ann Allergy Clin Immunol. 2015;47(1): 10-4. PMID: 25599553.
  115. Sanitarno-e’pidemiologicheskie pravila i normy’ SanPiN 3.3686-21 «Sanitarno-e’pidemiologicheskie trebovaniya po profilaktike infekcionny’x boleznej», utv. Postanovleniem Glavnogo gosudarstvennogo sanitarnogo vracha RF ot 28 yanvarya 2021 g. №4. (In Russ.).
  116. Briko NI, Mindlina AYa, Galina NP, Korshunov VA, Polibin RV. Adherence to immunoprevention: how to change the situation? Fundamental and Clinical Medicine. 2019;4(4):8-18. (In Russ.). https://doi.org/10.23946/2500-0764-2019-4-4-8-18
  117. Briko NI, Korshunov VA, Mindlina AY, Polibin RV, Antipov MO, Brazhnikov AI, Vyazovichenko YE, Glushkova EV, Lomonosov KS, Lomonosova AV, Lopukhov PD, Pozdnyakov AA, Saltykova TS, Torchinsky NV, Tsapkova NN, Chernyavskaya OP, Shamis AV. Healthcare Workers’ Acceptance of COVID-19 Vaccination in Russia. Int J Environ Res Public Health. 2022; 19:4136. https://doi.org/10.3390/ijerph19074136
  118. Briko NI, Korshunov VA, Mindlina AY, Polibin RV, Shamis AV, Saltykova AG. The Role of the Educational Programs in the Improving of Confidence in Vaccination against Pneumococcal Infection among Population. Epidemiology and Vaccinal Prevention. 2022;21(1): 92-97. (In Russ.). https://doi.org/10.31631/2073-3046-2022-21-1-92-97

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.